Commercial-grade 4-methyl-2-(pyridin-3-yl)thiazole-5-carboxylic acid is supplied as a crystalline hemihydrate with a lot-specific water content of 2.8–3.4 wt% determined by Karl Fischer titration in accordance with Ph. Eur. 2.5.12. The free carboxylic acid exhibits a pKa of 3.62 ± 0.10 (25 °C, 0.1 M NaClO₄) and undergoes decarboxylative degradation when heated above 217 °C in air, a threshold confirmed by differential scanning calorimetry at a scan rate of 10 K/min. Residual palladium, copper, and iron are controlled below 10 ppm per ICH Q3D Elemental Impurities Guideline Table A.2.1, making the material suitable for downstream synthetic steps where metal-sensitive cross-coupling catalysts are employed.
What Limits Amide Coupling Efficiency at Scale with 4-Methyl-2-(Pyridin-3-Yl)Thiazole-5-Carboxylic Acid?
The primary bottleneck in >50 kg batch reactors is the formation of an unreactive N-acylurea by-product when carbodiimide coupling agents such as EDC·HCl are exposed to residual free water in the solvent matrix. To suppress this side reaction, the acid is slurried in anhydrous dichloromethane (water content <50 ppm by coulometric titration) and pre-activated with 1.05 equivalents of HOBt and 1.00 equivalent of EDC·HCl at 0–5 °C for 45 minutes before the amine nucleophile is introduced. On a 200 L glass-lined steel vessel equipped with a retreat-curve impeller operating at 120 rpm, the addition sequence directly dictates the diastereomeric purity of the downstream amide; inverted addition—where amine is charged prior to full activation—yields 4.2–6.8% of the N-acylurea contaminant detectable by HPLC at retention time 11.34 min column: C18, 5 µm, 250 × 4.6 mm, isocratic acetonitrile/0.1% TFA (65:35). The validated synthetic protocol adheres to ICH Q7 sections 8.1 (process equipment) and 12.1 (process validation). The terminal actives produced via this intermediate include heterocyclic peptidomimetics evaluated as Factor XIa inhibitors and a series of triazolopyridyl-thiazole carboxamides that occupy the ATP-binding pocket of mutated EGFR kinases. In both target classes, residual thiazole acid must be controlled below 0.15% by area normalization in the final API; a dedicated reverse-phase flash chromatography step with Merck LiChroprep® RP-18 silica gel and a step gradient from 15% to 45% methanol in ammonium acetate buffer (pH 4.8) achieves the specification when the crude mixture is injected at a loading of 8 g per 100 g of stationary phase.
Adoption of 4-methyl-2-(pyridin-3-yl)thiazole-5-carboxylic acid as a transient directing group in palladium-catalyzed C(sp²)–H acetoxylation exploits the synergistic coordination of the pyridyl nitrogen and the deprotonated carboxylate oxygen to form a five-membered palladacycle. Under the conditions validated on a 2 L jacketed Hastelloy reactor with a pitched-blade turbine providing a Reynolds number of 2 400 in the turbulent regime, the catalytic loading is set at 10 mol% Pd(OAc)₂, 1.5 equiv of the thiazole acid relative to the arene substrate, and 2.0 equiv of PhI(OAc)₂ as the terminal oxidant in 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) at 40 °C for 18 hours under an oxygen-free nitrogen blanket. Process analytical technology with an in-line ReactIR™ 45m probe tracking the characteristic carboxylate ν(C=O) shift from 1712 cm⁻¹ (free acid) to 1685 cm⁻¹ (Pd-bound) determines the endpoint without manual sampling. Palladium black precipitation—a frequent failure mode when the agitation rate drops below 400 rpm—is suppressed by maintaining a constant 0.5 barg overpressure and filtering the hot reaction mixture in-line through a 0.45 µm PTFE membrane prior to workup. Compliance with ISO 10993-18 is not required at this stage; however, all isolated intermediates are tested for residual palladium via ICP-MS per USP <233>, with an acceptance criterion of <20 ppm. The structural motif installed via this directing-group strategy enables the synthesis of ortho-acetoxylated biaryl building blocks that are incorporated into macrocyclic hepatitis C NS3/4A protease inhibitors; the client batch records document that for a 10.0 kg input of the thiazole acid, a 78% isolated yield of the mono-acetoxylated regioisomer is consistently obtained with a para/ortho selectivity of ≥ 12:1 as measured by quantitative 19F NMR using 4-fluorobenzotrifluoride as an internal standard.
N-Substituted Pyridinylthiazole Carboxamide Fungicide Candidate Libraries
In early-stage agrochemical discovery groups, the acid is delivered as a neat solid with a bulk density of 0.52 g/cm³ and a median particle size D₅₀ of 75 µm to ensure rapid dissolution in ethyl acetate during the parallel synthesis of amide libraries. The carboxamide bond is constructed using the acid chloride method: neat thionyl chloride (3.0 molar equivalents, predistilled over quinoline) is added dropwise to a suspension of the acid in toluene containing 0.5% v/v DMF as a catalyst; the mixture is heated to gentle reflux (82 °C internal) until gas evolution ceases, typically 4.5 hours as monitored by a dry NaOH scrubber exhaust flow meter. The resulting acyl chloride—an amber oil with a density of 1.31 g/mL at 25 °C—is used without further isolation. It is added at 1.03 equivalents to a solution of the desired substituted aniline or heterocyclic amine in anhydrous tetrahydrofuran containing 1.1 equivalents of triethylamine at −10 °C. The downstream synthetic process is validated on a 100 mL multi-reactor cascade using overhead stirring with a 6-blade Rushton turbine at 800 rpm, ensuring that the heat of reaction (ΔHrxn = −238 kJ/mol determined by RC1e calorimetry) does not cause the bulk temperature to exceed 5 °C. Agrochemical intermediates manufactured under this route comply with analytical release specifications aligned with CIPAC Handbook M, method MT 30.2 (melting point) and MT 58.4 (water by Karl Fischer); additionally, absence of genotoxic chlorinated side products is confirmed by GC-MS with an LOQ of 0.05% using a 30 m × 0.25 mm × 0.25 µm DB-5MS column. The ultimate target products are experimental systemic acquired resistance inducers and succinate dehydrogenase inhibitor (SDHI) chemotypes containing the 2-(pyridin-3-yl)thiazole pharmacophore, specifically designed for control of Septoria tritici blotch on winter wheat at field rates of 75–125 g a.i./ha.
| Parameter | Test Method | Pharmaceutical Use Limit | Agrochemical Use Limit | Catalyst/Directing-Group Use Limit |
|---|---|---|---|---|
| Assay (anhydrous basis) | HPLC, external standard, 210 nm | ≥ 99.0% | ≥ 98.0% | ≥ 97.5% |
| Water content | Ph. Eur. 2.5.12 | ≤ 3.5% (as hemihydrate) | ≤ 4.0% | <500 ppm (predried for anhydrous applications) |
| Residue on ignition | Ph. Eur. 2.4.16 | ≤ 0.1% | ≤ 0.2% | ≤ 0.05% |
| Palladium content | USP <233> ICP-MS | ≤ 10 ppm | ≤ 20 ppm | ≤ 5 ppm |
| Chloride (derived from SOCl₂) | Ion chromatography, DIN 38405-19 | ≤ 50 ppm | ≤ 100 ppm | ≤ 200 ppm |
In solid-phase peptide synthesis protocols employing Fmoc-chemistry on a PEG-based ChemMatrix® resin with a substitution of 0.35 mmol/g, 4-methyl-2-(pyridin-3-yl)thiazole-5-carboxylic acid functions as an N-terminal-capping group that imparts enhanced proteolytic resistance and chelation capacity to linear and cyclic peptides. Because the thiazole ring is devoid of amine functionality, the acid is introduced as the carboxyl component in a HATU-mediated coupling following final deprotection of the N-terminal Fmoc protecting group. The standardized coupling cocktail consists of 4.0 equivalents of the thiazole acid (relative to resin-bound amine), 3.95 equivalents of HATU, and 8.0 equivalents of N,N-diisopropylethylamine in N-methyl-2-pyrrolidone; the mixture is pre-activated for 90 s before addition to the resin, and the acylation proceeds for 45 min at 25 °C with gentle nitrogen bubbling. A Kaiser test performed after a mini-cleavage confirms the absence of free amino groups. The modified peptide-resin is rinsed with DMF (5 × 10 mL per gram of resin), DCM (3 × 10 mL), and dried under vacuum at 35 °C overnight. Global deprotection and cleavage is accomplished with a mixture of 95% TFA, 2.5% triisopropylsilane, and 2.5% water; the crude product is precipitated in cold diethyl ether (−20 °C), centrifuged at 4 500 × g for 12 min, and lyophilized. The resulting capped peptides are subsequently purified on a 150 × 21.2 mm C18 preparative HPLC column with a mobile phase gradient of acetonitrile in 0.1% aqueous TFA. The entire procedure complies with the peptide impurity profiling guidelines described in Ph. Eur. general chapter 5.4 (residual TFA ≤ 0.1%) and ICH Q6B specifications for biotechnology-derived products when the peptide is a therapeutic candidate. Terminally capped products include [³⁸Leu,⁴¹N-(thiazolecarbonyl)]-analogues of exenatide and covalent rev peptide inhibitors of enteroviral 3C protease, where the pyridinyl-thiazole moiety engages in a hydrogen bond with the Gln¹⁹² side chain as confirmed by X-ray co-crystal structures deposited in the PDB.
When Rigid Heterocyclic Dicarboxylates Are Required for Gas Separation: Lanthanide-Based Coordination Polymers
The thiophilic nature of the pyridin-3-yl-thiazole fragment directs the construction of lanthanide-organic frameworks with tunable CO₂/CH₄ selectivity. In a typical solvothermal preparation, 0.40 mmol (0.088 g) of 4-methyl-2-(pyridin-3-yl)thiazole-5-carboxylic acid is deprotonated with 0.80 mmol of sodium hydroxide in 8 mL of deionized water, then combined with 0.20 mmol of europium nitrate hexahydrate or terbium nitrate pentahydrate dissolved in 4 mL of ethanol. The clear solution is sealed in a 23 mL PTFE-lined autoclave and heated under autogenous pressure at 120 °C for 72 h; a heating ramp of 2 °C/min is critical to avoid nucleation of amorphous metal oxide impurities that later interfere with the BET surface area measurement. Crystalline rods are harvested by centrifugation, washed with ethanol (3 × 25 mL), and activated at 150 °C under dynamic vacuum (pressure <10⁻³ mbar) for 18 h to fully evacuate the solvent from the one-dimensional channels. The composition of the final product is confirmed to be [Eu(L)(H₂O)₂]·2H₂O by simultaneous thermogravimetric analysis–differential thermal analysis (TGA–DTA) at a heating rate of 5 °C/min under flowing nitrogen (50 mL/min), showing an initial mass loss of 6.3% (calc. for two lattice water molecules: 6.1%). The permanent porosity of the activated material is determined by N₂ sorption at 77 K following ISO 9277:2022 (BET method); the Type I isotherm yields a specific surface area of 425 m²/g and a micropore volume of 0.22 cm³/g. Ideal adsorbed solution theory (IAST) predictions based on pure-component CO₂ and CH₄ isotherms collected at 298 K and pressures up to 1 bar indicate a selectivity factor of 28.5 for a 15/85 CO₂/CH₄ mixture, placing the material in the performance window required for biogas upgrading. The end product is evaluated as a packed adsorbent in an automated multi-column breakthrough analyzer configured with a 50 mm stainless steel column (4.6 mm I.D.) and mass flow controllers calibrated for 5–100 sccm.
Bioconjugation and Time-Resolved Fluorescence Resonance Energy Transfer Probe Assembly
Delivering the 4-methyl-2-(pyridin-3-yl)thiazole-5-carboxylate moiety as a sensitized antenna ligand for europium luminescence relies on the chelate effect of the pyridine nitrogen and the deprotonated carboxylate oxygen, which displace water molecules from the inner coordination sphere of the lanthanide ion and thereby suppress nonradiative decay. The acid is first converted into an activated succinimidyl ester by reacting 1.0 equivalent of the acid with 1.1 equivalents of N-hydroxysuccinimide and 1.05 equivalents of N,N′-dicyclohexylcarbodiimide in dry acetonitrile at 0 °C for 16 h; the precipitated N,N′-dicyclohexylurea is removed by filtration through Celite® 545, and the filtrate is used directly for lysine ε-amine conjugation on antibody fragments. The conjugation reaction employs a 15-fold molar excess of the NHS-ester relative to the Fab′ fragment in 50 mM sodium borate buffer (pH 8.8) containing 10% v/v DMSO for 2 h at ambient temperature, followed by quenching with 50 mM Tris-HCl (pH 7.4) and desalting on a PD-10 column pre-equilibrated with PBS. The labeling efficiency, measured by MALDI-TOF mass spectrometry in linear mode, reaches 3.2–3.8 chelating groups per Fab′ fragment without evidence of aggregation on dynamic light scattering (Z-average diameter ≤ 8.5 nm). Upon addition of EuCl₃·6H₂O at 2.0 equivalents per chelator in a nitrilotriacetic acid-free Tris buffer at pH 7.0, the conjugate exhibits a characteristic europium emission at 615 nm (⁵D₀→⁷F₂ transition) with a lifetime of 0.84 ms measured on a time-resolved fluorescence plate reader. The entire bioconjugation protocol complies with ICH Q5C (stability testing of biotechnological products) and uses reagents that pass endotoxin testing by the LAL kinetic chromogenic method (Ph. Eur. 2.6.14) with a threshold of <0.05 EU/mg. The resulting luminescent probes serve as donor fluorophores in homogeneous immunoassays for cardiac troponin I and as time-resolved FRET acceptors partnered with allophycocyanin-labeled streptavidin in a commercial interleukin-17 detection kit.
| Application | Key Process Parameter | Operating Range / Setpoint | Failure Boundary | Monitoring Technique |
|---|---|---|---|---|
| Scale-up amide coupling | Activation temperature | 0–5 °C | >8 °C accelerates N-acylurea formation | In-tank Pt100 probe, ±0.3 °C accuracy |
| C–H acetoxylation | Agitator tip speed | 1.2–1.8 m/s | <0.9 m/s leads to Pd black precipitation | Variable-frequency drive feedback |
| Fungicide acid chloride generation | Heating ramp rate to reflux | 2.0 °C/min | >3.5 °C/min causes exothermic SO₂ surge | Calorimetric power compensation (RC1e) |
| N-terminal peptide capping | Pre-activation time of HATU mixture | 90 s | <40 s yields incomplete acylation; >3 min leads to epimerization of adjacent amino acid | HPLC monitoring of model dipeptide |
| MOF solvothermal synthesis | Autogenous pressure vessel fill ratio | 42–48% of free volume | <35% crystallization yields amorphous product; >55% risk of over-pressurization at 120 °C | Fill volume verified by gravimetric balance |
| Fab′ conjugation | Reaction buffer pH | 8.6–8.9 | <8.3 drastically slows NHS-ester aminolysis; >9.2 promotes hydroxamate formation from NHS ester | Single-junction pH microelectrode |
When a compound library requires the systematic exploration of structure–activity relationships at the hinge region of adenine nucleotide-binding enzymes, the thiazole-5-carboxylic acid is deployed as a fragment that simultaneously donates and accepts hydrogen bonds via the pyridine nitrogen and the thiazole π-system. The acid is dissolved in dry dimethylacetamide at a concentration of 0.2 M and dispensed into 96-well glass reactor blocks using a positive-displacement pipette calibrated for ±2.5% accuracy at 50 µL; each well receives 0.12 mmol of the acid, 0.125 mmol of ethyl cyano(hydroxyimino)acetate (OxymaPure®), and 0.125 mmol of N,N′-diisopropylcarbodiimide, followed by 0.10 mmol of the scaffold amine dissolved in 200 µL of dichloromethane. The blocks are sealed under argon and shaken at 500 rpm with a 2 mm orbital throw for 18 h at 22 °C. For workup, the mixtures are transferred to phase-separator fritted plates containing 500 µL of 0.5 M aqueous HCl and 700 µL of ethyl acetate per well; organic layers are evaporated in a 96-tip centrifugal evaporator with a heating plate set to 35 °C and a vacuum ramp from 200 mbar to 10 mbar over 60 min. All products must pass a purity threshold of ≥ 90% by LC-MS (UV purity at 254 nm and 220 nm, ESI positive mode) to advance to the primary screen. The protocol is conducted under ISO 17025 accredited laboratory conditions and meets the reporting standards of the NIH Analytical Chemistry Core for fragment-based drug discovery. Terminal compounds range from indazole-3-carboxamide kinase insert domain binders to pyrazolo[1,5-a]pyrimidine-3-carboxylates targeting p38α MAP kinase, many of which incorporate the pyridinylthiazole subunit as a hinge-binding element that displaces a conserved water molecule observed in room-temperature crystallography.
